Medpace Holdings
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
35.9130.5326.4621.46
Price/Sales ratio
6.725.835.074.08
Earnings per Share (EPS)
$13.14$15.45$17.83$21.99

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-52.52-126.9896.1236.2825.8130.1134.2243.0228.0533.2924.3530.11
Price/Sales ratio
2.823.063.053.242.673.505.356.834.714.994.092.67
Price/Book Value ratio
2.032.662.102.813.194.156.158.1917.8016.8415.463.19
Price/Cash Flow ratio
10.8713.0914.0314.5412.0114.9419.1729.6317.7221.7215.3912.01
Price/Free Cash Flow ratio
11.7014.1816.4616.6413.3816.3921.8133.2019.5923.7316.6413.38
Price/Earnings Growth ratio
0.372.69-0.400.220.240.830.741.760.561.540.530.24
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
46.10%43.55%40.82%40.05%30.58%28.53%30.10%28.72%29.61%27.81%29.61%29.61%
Operating Profit Margin
8.96%9.21%12.45%14.87%14.34%14.78%18.04%17.38%19.08%17.86%19.08%14.34%
Pretax Profit Margin
-7.33%-2.18%5.20%13.05%13.33%14.49%18.20%17.66%19.37%17.80%19.37%13.33%
Net Profit Margin
-5.36%-2.41%3.17%8.94%10.34%11.63%15.65%15.87%16.79%14.99%16.80%10.34%
Effective Tax Rate
-26.75%-10.76%38.85%31.29%22.10%19.53%13.73%9.91%13.25%15.75%13.25%19.53%
Return on Assets
-1.41%-0.88%1.36%4.10%7.53%8.76%10.42%10.92%18.13%17.06%18.14%7.53%
Return On Equity
-3.87%-2.09%2.19%7.75%12.36%13.79%17.98%19.03%63.46%50.59%60.41%12.36%
Return on Capital Employed
2.69%3.89%6.47%8.55%14.21%15.90%17.57%18.01%50.76%46.03%50.76%14.21%
Liquidity Ratios
Current Ratio
N/AN/A0.790.670.690.921.07N/AN/AN/A0.410.92
Quick Ratio
0.980.680.780.670.690.921.071.230.410.640.350.92
Cash ratio
0.400.110.220.130.090.380.630.820.030.260.030.38
Days of Sales Outstanding
82.1166.1669.0669.5269.1365.9963.4559.5663.3557.7563.3565.99
Days of Inventory outstanding
2.575.140.450.000.000.00N/AN/AN/AN/AN/A0.00
Operating Cycle
84.6871.3169.5169.5369.1365.9963.4559.5663.3557.7515.6265.99
Days of Payables Outstanding
14.5915.7115.9623.2712.4913.2914.9711.5111.748.5411.7413.29
Cash Conversion Cycle
70.0855.5953.5446.2556.6452.7048.4748.0551.6049.2051.6052.70
Debt Ratios
Debt Ratio
0.440.380.160.230.08N/AN/AN/A0.03N/A0.710.08
Debt Equity Ratio
1.220.910.260.440.13N/AN/AN/A0.12N/A2.500.13
Long-term Debt to Capitalization
0.550.470.190.280.11N/AN/AN/AN/AN/A0.260.11
Total Debt to Capitalization
0.550.470.210.300.11N/AN/AN/A0.11N/A0.320.11
Interest Coverage Ratio
N/AN/A2.708.5812.3881.16N/AN/AN/AN/A92.4912.38
Cash Flow to Debt Ratio
0.150.220.560.431.96N/AN/AN/A7.76N/A2.051.96
Company Equity Multiplier
2.722.371.601.881.641.571.721.743.502.963.501.64
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.250.230.210.220.220.230.270.230.260.220.260.22
Free Cash Flow / Operating Cash Flow Ratio
0.920.920.850.870.890.910.870.890.900.910.920.89
Cash Flow Coverage Ratio
0.150.220.560.431.96N/AN/AN/A7.76N/A2.051.96
Short Term Coverage Ratio
N/AN/A7.415.90N/AN/AN/AN/A7.76N/A7.76N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A